Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth

AMGN beats first-quarter estimates for earnings and sales. Sales of most of its products, Prolia, Xgeva, Repatha, Blincyto and Evenity beat estimates....

Zacks Investment Research - 5/2/2025 8:50:36 AM More News for AMGN
Stock Analysis for AMGN
Related Stocks: